Planning

Microbiology Serology Testing Managed Service

NHS BLOOD AND TRANSPLANT

This public procurement record has 1 release in its history.

Planning

21 Apr 2023 at 14:24

Summary of the contracting process

The NHS Blood and Transplant organization has initiated a tender for a "Microbiology Serology Testing Managed Service" in the laboratory services industry category. The procurement process is currently in the planning stage with a future notice date set for 31 August 2023. Interested suppliers are required to submit an expression of interest by 29 May 2023. The contract, with an estimated value of £50,000,000 GBP, aims to support the delivery of Microbiology Serological screening/testing of blood and non-blood donations. The tender includes requirements for testing capabilities at various testing sites and mandates the use of CE/UKCA marked medical devices.

This tender presents business growth opportunities for companies providing diagnostic devices, laboratory services, medical consumables, and immuno-analysis devices. Suppliers offering automated instrumentation, high-throughput testing solutions, and innovation in sample presentation technology are well-suited to compete. The procurement seeks to develop a robust marketplace understanding and foster supplier engagement through events scheduled for June 2023. Businesses must ensure compliance with the Guidelines for the Blood Transfusion service in the United Kingdom and participate in the Kit Evaluation Group approval process to be considered for contract award.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Microbiology Serology Testing Managed Service

Notice Description

The purpose of this Prior Information Notice is to:<br/>* Alert potential suppliers that NHS Blood and Transplant intends to let a managed service contract which supports the delivery of Microbiology Serological screening/ testing of blood and non-blood donations. NOTE: The estimated total value below is based on a maximum 10-year contract duration.<br/>* Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support and innovation.<br/>* Make potential suppliers aware of the Kit Evaluation Group (KEG) and their assessment process for assays<br/><br/>An expression of interest must be e-mailed to Daniel.Kirkbride@nhsbt.nhs.uk by no later than Monday 29 May 2023, which includes the following:<br/>* Company Name and Address<br/>* Company point of contact details (Name, role, email and contact number)<br/>* Copies of the relevant assay Instructions for Use<br/><br/>Upon expressing an interest, potential suppliers will be sent a further request for information, to aid discussions at supplier engagement events to be arranged for June 2023. The formal publication of the procurement is planned for August/ September 2023.

Lot Information

Lot 1

NHSBT undertakes Microbiology Serology testing across three testing sites, the largest being Manchester and Filton testing laboratories. These test approximately 1.7 million donations per annum, which includes tests on blood, tissue and stem cell donations.

The third site, Microbiology Services Laboratory (MSL) in Colindale, tests approximately 5k donations per annum. MSL tests non-blood donations (tissue and stem cell), including those from deceased (not heart beating) tissue donors as well as undertaking confirmatory testing of screen reactive blood donations

Donation testing laboratories in Manchester and Filton perform the following tests:
* Hepatitis B (HBsAg) *
* Hepatitis B core (anti-HBc) **
* Hepatitis B antibody (anti-HBs) ***
* Human immunodeficiency virus (HIV 1&2 Ab/Ag) *
* Hepatitis C (anti-HCV) *
* Syphilis antibodies *
* Human T-lymphotropic virus I/II (anti-HTLV) *
* Cytomegalovirus (CMV) IgG or Total antibody **
* Malarial antibody (anti-malaria) **
* Trypanosome cruzi (anti-T. cruzi) **

The Microbiology Services Laboratory (MSL) in Colindale performs the following tests:
* Hepatitis B (HBsAg) *
* Hepatitis B antibodies (anti-HBc) **
* Human immunodeficiency virus (HIV 1&2 Ab/Ag) *
* Hepatitis C (anti-HCV) *
* Syphilis antibodies *
* Human T-lymphotropic virus I/II (anti-HTLV) *
* Cytomegalovirus (CMV) IgG or Total antibody **
* Malarial antibody (anti-malaria) **
* Trypanosome cruzi (anti-T. cruzi) **
* Cytomegalovirus (CMV) IgM ***
* Hepatitis B antibodies (anti-HBs) ***
* Mandatory requirement
** On selected donations
*** Where required

Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and therefore the assays used in MSL must be suitable for deceased donor screening.

Automated instrumentation is required to enable high throughput testing of mandatory and additional testing for blood and non-blood donors. Archiving and long-term storage of plasma samples is also required. Consideration will be given to all efficiency and innovation opportunities, including, but not limited to, middleware and sample presentation technology.

The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT systems without the need for development to NHSBT host IT systems.

All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (www.transfusionguidelines.org/red-book).

In accordance with the Guidelines for the Blood Transfusion service in the United Kingdom, Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of contract. The submission of your assay Instructions for Use will allow a desktop review of high-level mandatory requirements. If the high-level mandatory requirements are met during the desktop review, organisations will be invited to participate in the KEG process and be asked to formally submit FRM51 "Application for NHSBT Evaluation of Microbiology Test Kit", a copy of which will supplied by NHSBT following a successful desktop review.

All in-vitro diagnostic medical devices, for example: instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2024 and from 01 July 2024 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03c346
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/011542-2023
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

71 - Architectural, construction, engineering and inspection services


CPV Codes

33124100 - Diagnostic devices

33124110 - Diagnostic systems

33124130 - Diagnostic supplies

33127000 - Immuno-analysis devices

33140000 - Medical consumables

33141625 - Diagnostic kits

33190000 - Miscellaneous medical devices and products

33696200 - Blood-testing reagents

33696500 - Laboratory reagents

71900000 - Laboratory services

Notice Value(s)

Tender Value
£50,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
21 Apr 20232 years ago
Submission Deadline
Not specified
Future Notice Date
30 Aug 2023Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Daniel Kirkbride
Contact Email
daniel.kirkbride@nhsbt.nhs.uk
Contact Phone
+44 7764280366

Buyer Location

Locality
BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-03c346-2023-04-21T15:24:56+01:00",
    "date": "2023-04-21T15:24:56+01:00",
    "ocid": "ocds-h6vhtk-03c346",
    "initiationType": "tender",
    "tender": {
        "id": "C166166 (Project Ref)",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Microbiology Serology Testing Managed Service",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "71900000",
            "description": "Laboratory services"
        },
        "mainProcurementCategory": "services",
        "description": "The purpose of this Prior Information Notice is to:<br/>* Alert potential suppliers that NHS Blood and Transplant intends to let a managed service contract which supports the delivery of Microbiology Serological screening/ testing of blood and non-blood donations. NOTE: The estimated total value below is based on a maximum 10-year contract duration.<br/>* Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support and innovation.<br/>* Make potential suppliers aware of the Kit Evaluation Group (KEG) and their assessment process for assays<br/><br/>An expression of interest must be e-mailed to Daniel.Kirkbride@nhsbt.nhs.uk by no later than Monday 29 May 2023, which includes the following:<br/>* Company Name and Address<br/>* Company point of contact details (Name, role, email and contact number)<br/>* Copies of the relevant assay Instructions for Use<br/><br/>Upon expressing an interest, potential suppliers will be sent a further request for information, to aid discussions at supplier engagement events to be arranged for June 2023. The formal publication of the procurement is planned for August/ September 2023.",
        "value": {
            "amount": 50000000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "NHSBT undertakes Microbiology Serology testing across three testing sites, the largest being Manchester and Filton testing laboratories. These test approximately 1.7 million donations per annum, which includes tests on blood, tissue and stem cell donations.<br/><br/>The third site, Microbiology Services Laboratory (MSL) in Colindale, tests approximately 5k donations per annum. MSL tests non-blood donations (tissue and stem cell), including those from deceased (not heart beating) tissue donors as well as undertaking confirmatory testing of screen reactive blood donations<br/><br/>Donation testing laboratories in Manchester and Filton perform the following tests:<br/>* Hepatitis B (HBsAg) *<br/>* Hepatitis B core (anti-HBc) **<br/>* Hepatitis B antibody (anti-HBs) ***<br/>* Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>* Hepatitis C (anti-HCV) *<br/>* Syphilis antibodies *<br/>* Human T-lymphotropic virus I/II (anti-HTLV) *<br/>* Cytomegalovirus (CMV) IgG or Total antibody **<br/>* Malarial antibody (anti-malaria) **<br/>* Trypanosome cruzi (anti-T. cruzi) **<br/><br/>The Microbiology Services Laboratory (MSL) in Colindale performs the following tests:<br/>* Hepatitis B (HBsAg) *<br/>* Hepatitis B antibodies (anti-HBc) ** <br/>* Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>* Hepatitis C (anti-HCV) *<br/>* Syphilis antibodies *<br/>* Human T-lymphotropic virus I/II (anti-HTLV) *<br/>* Cytomegalovirus (CMV) IgG or Total antibody **<br/>* Malarial antibody (anti-malaria) ** <br/>* Trypanosome cruzi (anti-T. cruzi) **<br/>* Cytomegalovirus (CMV) IgM ***<br/>* Hepatitis B antibodies (anti-HBs) ***<br/>* Mandatory requirement<br/>** On selected donations<br/>*** Where required<br/><br/>Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and therefore the assays used in MSL must be suitable for deceased donor screening.<br/><br/>Automated instrumentation is required to enable high throughput testing of mandatory and additional testing for blood and non-blood donors. Archiving and long-term storage of plasma samples is also required. Consideration will be given to all efficiency and innovation opportunities, including, but not limited to, middleware and sample presentation technology.<br/><br/>The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT's host IT systems without the need for development to NHSBT host IT systems.<br/><br/>All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (www.transfusionguidelines.org/red-book). <br/><br/>In accordance with the Guidelines for the Blood Transfusion service in the United Kingdom, Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of contract. The submission of your assay Instructions for Use will allow a desktop review of high-level mandatory requirements. If the high-level mandatory requirements are met during the desktop review, organisations will be invited to participate in the KEG process and be asked to formally submit FRM51 \"Application for NHSBT Evaluation of Microbiology Test Kit\", a copy of which will supplied by NHSBT following a successful desktop review.<br/><br/>All in-vitro diagnostic medical devices, for example: instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2024 and from 01 July 2024 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33190000",
                        "description": "Miscellaneous medical devices and products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33124100",
                        "description": "Diagnostic devices"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33141625",
                        "description": "Diagnostic kits"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33124110",
                        "description": "Diagnostic systems"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33696200",
                        "description": "Blood-testing reagents"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33696500",
                        "description": "Laboratory reagents"
                    },
                    {
                        "scheme": "CPV",
                        "id": "71900000",
                        "description": "Laboratory services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33140000",
                        "description": "Medical consumables"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33127000",
                        "description": "Immuno-analysis devices"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33124130",
                        "description": "Diagnostic supplies"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "NHSBT Filton, 500 North Bristol Park Northway, Filton, Bristol BS34 7QH<br/>NHSBT Manchester, Plymouth Grove, Manchester M13 9LL<br/>NHSBT Colindale, Charcot Road, Colindale, London NW9 5BG"
                },
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2023-08-31T00:00:00+01:00",
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        }
    },
    "parties": [
        {
            "id": "GB-FTS-18293",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "legalName": "NHS Blood and Transplant"
            },
            "address": {
                "streetAddress": "500 North Bristol Park",
                "locality": "Bristol",
                "region": "UKK11",
                "postalCode": "BS34 7QH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Daniel Kirkbride",
                "telephone": "+44 7764280366",
                "email": "daniel.kirkbride@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.nhsbt.nhs.uk/",
                "buyerProfile": "https://www.nhsbt.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-18293",
        "name": "NHS Blood and Transplant"
    },
    "language": "en"
}